Literature DB >> 11920271

Total deficiency of specific von Willebrand factor-cleaving protease and recovery following plasma therapy in one patient with hemolytic-uremic syndrome.

A Veyradier, F Brivet, M Wolf, C Boyer-Neumann, B Obert, J P Girma, D Meyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11920271     DOI： 10.1038/sj.thj.6200126

Source DB:  PubMed          Journal:  Hematol J        ISSN： 1466-4860


× No keyword cloud information.
  3 in total

Review 1.  Thrombotic thrombocytopenic purpura: recognition and management.

Authors:  Joseph E Kiss
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490

2.  A shear-based assay for assessing plasma ADAMTS13 activity and inhibitors in patients with thrombotic thrombocytopenic purpura.

Authors:  Yue Han; Juan Xiao; Erica Falls; X Long Zheng
Journal:  Transfusion       Date:  2011-01-20       Impact factor: 3.157

Review 3.  The kidney in thrombotic thrombocytopenic purpura.

Authors:  H-M Tsai
Journal:  Minerva Med       Date:  2007-12       Impact factor: 4.806
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.